Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    9 Meters Biopharma Inc.

    NASDAQ: NMTR · Real-Time Price · USD
    0.07
    -0.06 (-44.71%)
    At close: Jul 25, 2023, 10:00 PM

    9 Meters Biopharma Statistics

    Share Statistics

    9 Meters Biopharma has 14.46M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 14.46M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 12.75M

    Failed to Deliver (FTD) Shares

    n/a
    		 730

    FTD / Avg. Volume

    n/a
    		 0.16%

    Short Selling Information

    The latest short interest is 580.63K, so 4.02% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 580.63K

    Short % of Shares Out

    n/a
    		 4.02%

    Short % of Float

    n/a
    		 4.08%

    Short Ratio (days to cover)

    n/a
    		 16.57

    Valuation Ratios

    The PE ratio is -0.36 and the forward PE ratio is null. 9 Meters Biopharma's PEG ratio is -0.02.

    PE Ratio

    n/a
    		 -0.36

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 6.8

    P/FCF Ratio

    n/a
    		 -0.44

    PEG Ratio

    n/a
    		 -0.02
    Financial Ratio History

    Enterprise Valuation

    9 Meters Biopharma has an Enterprise Value (EV) of 23.41M.

    EV / Sales

    n/a
    		 0

    EV / EBITDA

    n/a
    		 -0.56

    EV / EBIT

    n/a
    		 -0.63

    EV / FCF

    n/a
    		 -0.63

    Financial Position

    The company has a current ratio of 1.08, with a Debt / Equity ratio of 8.22.

    Current Ratio

    n/a
    		 1.08

    Quick Ratio

    n/a
    		 1.08

    Debt / Equity

    n/a
    		 8.22

    Debt / EBITDA

    n/a
    		 -0.48

    Debt / FCF

    n/a
    		 -0.53

    Interest Coverage

    n/a
    		 -15.75

    Financial Efficiency

    Return on Equity is -1896.06% and Return on Invested Capital is -197.45%.

    Return on Equity

    n/a
    		 -1896.06%

    Return on Assets

    n/a
    		 -137.31%

    Return on Invested Capital

    n/a
    		 -197.45%

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-4,551,577.9

    Employee Count

    n/a
    		 10

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 1.75M

    Effective Tax Rate

    n/a
    		 -4%

    Stock Price Statistics

    The stock price has increased by 314.2% in the last 52 weeks. The beta is 1.48, so 9 Meters Biopharma's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.48

    52-Week Price Change

    n/a
    		 314.2%

    50-Day Moving Average

    n/a
    		 0.51

    200-Day Moving Average

    n/a
    		 1.37

    Relative Strength Index (RSI)

    n/a
    		 8.52

    Average Volume (20 Days)

    n/a
    		 446,108

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -42.02M

    Net Income

    n/a
    		 -45.52M

    EBITDA

    n/a
    		 -41.51M

    EBIT

    n/a
    		 -41.1M

    Earnings Per Share (EPS)

    n/a
    		 -3.51
    Full Income Statement

    Balance Sheet

    The company has 12.65M in cash and 19.73M in debt, giving a net cash position of -7.08M.

    Cash & Cash Equivalents

    n/a
    		 12.65M

    Total Debt

    n/a
    		 19.73M

    Net Cash

    n/a
    		 -7.08M

    Retained Earnings

    n/a
    		 -212.61M

    Total Assets

    n/a
    		 9.31M

    Working Capital

    n/a
    		 -6.38M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -37.24M and capital expenditures -2.84K, giving a free cash flow of -37.25M.

    Operating Cash Flow

    n/a
    		 -37.24M

    Capital Expenditures

    n/a
    		 -2.84K

    Free Cash Flow

    n/a
    		 -37.25M

    FCF Per Share

    n/a
    		 -2.87
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    NMTR does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -278.83%

    FCF Yield

    n/a
    		 -228.17%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for NMTR.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Oct 18, 2022. It was a backward split with a ratio of 1:20.

    Last Split Date

    n/a
    		 Oct 18, 2022

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:20

    Scores

    Altman Z-Score

    n/a
    		 -50.22

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist